MEANS FOR INHIBITING PROTEINKINASE 3 EXPRESSION

FIELD: medicine, pharmaceutics.SUBSTANCE: invention relates to the field of molecular biology, genetic engineering and medicine.EFFECT: claimed is a molecule of ribonucleic acid, mediating the RNA interference, aimed against PKN3, as well as a lipocomplex, containing thereof, a pharmaceutical compos...

Full description

Saved in:
Bibliographic Details
Main Authors ZANTEL', ANSGAR, KAJL', OLIVER, KAUFMANN, JORG
Format Patent
LanguageEnglish
Russian
Published 20.06.2015
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:FIELD: medicine, pharmaceutics.SUBSTANCE: invention relates to the field of molecular biology, genetic engineering and medicine.EFFECT: claimed is a molecule of ribonucleic acid, mediating the RNA interference, aimed against PKN3, as well as a lipocomplex, containing thereof, a pharmaceutical composition, application and method of treating cancer disease involving the PI3-kinase pathway.48 cl, 2 tbl, 17 dwg, 13 ex Изобретение относится к области молекулярной биологии, генетической инженерии и медицины. Предложена молекула рибонуклеиновой кислоты, опосредующая интерференцию РНК, нацеленной против PKN3, а также содержащий её липокомплекс, фармацевтическая композиция, применение и способ лечения ракового заболевания, в которое вовлечен путь PI3-киназы. 12 н. и 36 з.п. ф-лы, 2 табл., 17 ил., 13 пр.
Bibliography:Application Number: RU20090106071